The object of the present study was to determine whether the serotonin content of the brain could be markedly increased by peripheral medication, but without incurring the peripheral actions of this hormone (contractions of the intestines, increased blood pressure, etc.) at the same time. A further object was to determine whether the increased brain serotonin would then bring about behavioral changes in the animals-in other words, whether the excess hormone would still exert a central effect when some of the receptors in the periphery were blocked. The reasons for this study were the following.
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In 1954 Woolley and Shaw1' 2 presented evidence which indicated that certain mental disorders (e.g., schizophrenia) probably arose from a deficiency of serotonin in the brain. This deficiency was pictured as arising from a metabolic failure of the central nervous system to produce enough of this hormone. The nature of the evidence was such as to implicate serotonin in the etiology of the disease, but it did not unequivocally point to a deficiency rather than an excess of the hormone. 2 One of the purposes of the present investigation was to develop a method which might help distinguish between the alternate possibilities of too much or too little serotonin in the brain as the causative condition of the disorders.
The earlier work had shown1' 3 that serotonin, although it was formed both in the brain and in the carcass of an animal, did not pass readily between these two parts. Serotonin injected peripherally could not be detected by chemical procedures in the brain, apparently because it did not pass the blood-brain barrier. As a result, there seemed little hope of attempting to raise the serotonin content of the brain by peripheral administration of the hormone. This difficulty was clearly stated in the original paper, and subsequent clinical trials have substantiated it. For example, the peripheral injection of serotonin into patients suffering from schizophrenia has not alleviated the disease. Even if the causative factor in the disorder is a deficiency of serotonin in the brain, the mere administration of the hormone in the periphery could hardly be expected to increase the content of the brain. Direct injection of the hormone into the central nervous system is too dangerous to be contemplated in human subjects. Consequently, a means of changing brain serotonin levels by peripheral medication must be sought if the fundamental hypothesis is to be tested.
A means of doing this has recently been found. Udenfriend et al. 4 have found that the normal precursor -of serotonin, viz., 5-hydroxytryptophan, when injected peripherally into animals, passes the barrier and is converted into excess serotonin in the brain. Consequently the peripheral administration of this precursor has been found to increase the serotonin content of the brain.
Nevertheless, a serious difficulty attends the use of this precursor. Not only does it increase the serotonin content of the brain; it also markedly increases the hormone in the peripheral organs. The results of this are, among others, to increase blood pressure by vasoconstriction and to cause strong contractions of the intestines. We have found that the intestinal effects have been particularly noticeable. In animals (dogs, mice) profound diarrhea soon follows administration of 5-hydroxytryptophan. In human subjects Udenfriend5 has been dissuaded from further trials because of the profound discomfort of these intestinal contractions.
If a way could be found to protect the periphery from the excess serotonin which is formed when 5-hydroxytryptophan is administered, but without also protecting the central nervous system, then the means of testing the original hypothesis with relation to mental disorders would be available. For example, if one had an effective and specific antagonist of serotonin which, however, did not penetrate into the brain, the administration of this antagonist peripherally, followed by 5-hydroxytryptophan also given peripherally, should result in an increase in effective serotonin content of the brain. The peripheral actions of serotonin, however, should be prevented by the specific antagonist which would be confined there. The whole organism, both central nervous system and periphery, would be flooded with excess serotonin from the 5-hydroxytryptophan, but the actions of this excess hormone would be prevented in the peripheral tissues, while the actions in the central nervous system would be unhampered. The selective effect would result from the failure of the antagonist to pass freely into the brain.
The recent discovery of an antimetabolite of serotonin which is highly active against some of the peripheral actions of serotonin, but which seems not to penetrate freely into all parts of the central nervous system, now makes feasible a test of the considerations outlined above. This antimetabolite is 1-benzyl-2,5-dimethylserotonin, the benzyl analogue of serotonin, or BAS.6 7 The chief evidence which indicates that it passes into the brain with difficulty is that it does not cause psychiatric disturbances when given to humans. At doses which are able to antagonize several of the peripheral actions of excess serotonin (increase in blood pressure, contractions of the intestines), BAS did not disturb the mind. By contrast, several other antiserotonins have been shown to cause hallucinations or mental depressions." 3 The object of the present study was to determine whether the peripheral administration of BAS would protect animals from some of the peripheral effects of excess serotonin which arise from injected 5-hydroxytryptophan. The principal peripheral effect to be studied was intestinal contraction, as evidenced by diarrhea. At the same time, the concentration of serotonin in the brain was to be measured to determine whether the hormone was actually being increased in this organ. The central action of this excess cerebral serotonin was to be judged from the behavior of the animals. Sources of Materials.-BAS or 1-benzyl-2,5-dimethylserotonin hydrochloride was synthesized according to the method previously published by this laboratory.9
The 5-hydroxytryptophan was the racemic mixture synthesized according .to Ek and Witkop'°and purchased from the California Foundation for Biochemistry.
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Methods.-Adult Swiss female mice (25-30 gm. each) were divided into groups of twelve. Each mouse of the BAS groups was injected intraperitoneally with an aqueous solution of BAS, 1 mg. in 0.25 ml. Controls received Ringer's solution. Twenty hours later the injections were repeated. It was very important to pretreat with BAS before the administration of 5-hydroxytryptophan because the BAS was known to exert its maximal antiserotonin effect slowly.
Immediately after the last injection of BAS or saline, 5-hydroxytryptophan (either 2.5 mg. or 15 mg. per mouse) was injected intraperitoneally in 0.5 ml. of Ringer's solution. The animals were placed in individual glass jars and observed very closely for 1 hour. Their behavior was compared to that of controls which had received only saline or only BAS. They were then killed with chloroform, the brains were quickly removed, and analyzed for serotonin by the method of Udenfriend et al."1 This method was scaled down to accommodate the small samples available. This was done by taking larger aliquots of the butanol extract which contained the serotonin, and by use of only 1.2 ml. of acid for extraction from the heptane-butanol mixture. Because serotonin is rather unstable in alkaline solution, it was necessary to minimize the total time of exposure to pH 10 (7 minutes) and to insure that all samples and all standards were exposed for the same time. If this was not done, duplicate analyses frequently did not agree well. With these modifications the method for serotonin determination was found adequate to give good recoveries of added serotonin and yielded values similar to those given by pharmacological methods.
Result&-The data of Table 1 show that the serotonin content of mouse brains was not much changed by prior treatment of the animals with BAS alone. However, the additional administration of 5-hydroxytryptophan brought about a large increase. A dose of 2.5 mg. (100 mg/kg) raised the content appreciably, while 15 mg. caused a 10-fold increase. It was thus clear that mice treated with BAB and 5-hydroxytryptophan underwent a large increase in cerebral serotonin content. When the incidence of diarrhea is taken as a criterion of an effect of serotonin on the intestines, the data of the table clearly show that all of the animals were fully protected from this peripheral effect of the hormone. Prior studies had shown that BAS likewise protected animals from another peripheral action of serotonin, viz., the pressor effects.7
The diarrhea in mice receiving only 5-hydroxytryptophan was very severe. It began within a few minutes of the injection and continued for at least 2 hours. The same phenomenon has been noted in dogs. In view of the fact that 0.5 mg. of the compound per mouse caused a maximal response, the ability to protect all the animals which had received 30 times this dose (15 mg. per mouse) was impressive.
The behavioral changes in mice given both BAS and 5-hydroxytryptophan were indicative of profound effects on the central nervous system. This, then, was evidence that the increased cerebral serotonin was in fact still free to act in the central nervous system. Those animals which had received BAS and 2.5 mg. of the hydroxytryptophan showed a very marked quieting or tranquillization. They tended to stand rather close to the ground and not to move at all. They were not asleep, because they would walk when touched, but would soon resume a tranquil state. Control mice which had received the BAS alone without the hydroxytryptophan were noticeably more quiet than normal controls, but they were not affected nearly as much as the ones which had both compounds.
The tranquillity of the mice receiving BAS plus 2.5 mg. of hydroxytryptophan was in marked contrast to the behavior of those getting BAS plus 15 mg. These presented a picture of excitement. They looked rapidly from side to side with great agitation and constantly pranced in one spot and exhibited strong tremors. Their ears became red and their tails stiff. The hind legs were extended behind them. A few walked backward, and, while the behavior was distinguishable from that of mice given lysergic acid diethylamide,'2 the whole picture was somewhat similar to such LSD animals. Most of the mice treated with BAS plus 15 mg. of hydroxytryptophan seemed on the verge of convulsions, and, when they were killed with chloroform, the forward half of the body became very rigid immediately. It was noteworthy that mice which had received BAS plus hydroxytryptophan did not urinate as normal mice did or salivate as did mice given serotonin intracerebrally.
Behavioral Changes Caused by BAS Injected into the Brain.-In view of the absence of any behavioral change aside from lethargy brought about by peripheral BAS, the effects of intracerebral injection of this compound were tested. When mice were anesthetized with ether and BAS was injected into the lateral ventrical of the brain, pronounced behavioral changes were found. After the anesthesia had been dissipated, the animals began to show principally signs of excitement. About half an hour after the injection, they began to push backward and then to rear up on their haunches and fall over backward. Some of them walked backward in a manner similar to that of mice given lysergic acid diethylamide.'2 Occasionally convulsions were seen. All showed marked reddening of the ears. The behavioral changes appeared much later after the injection than was the case with mice given lysergic acid diethylamide, and the signs became progressively worse. Many animals died after about an hour. These effects were obtained by injection of 50-100 ug. per mouse and were studied in nine mice, all of which exhibited some of the changes. In most of the animals which had received intracerebral BAS, more time was required to awaken from ether anesthesia than with controls given only Ringer's solution.
At 30 ug. per mouse the excitement of the animals did not seem as prominent as at the higher doses. They still pushed backward and reared on their haunches, hut seemed more stunned than excited. This dose represents the amount of BAS which should have reached the brain after peripheral injection of 1 mg., provided that there had been equal distribution to all parts of the body. The behavioral change caused by the intracerebrally injected compound was in sharp contrast to the lack of such change in peripherally injected mice.
Discussion.-These results indicate that when 5-hydroxytryptophan was given to a mouse previously treated with BAS, there was complete protection against some of the effects, notably the contractions of the intestines. On the contrary, the central actions of the hydroxytryptophan were not prevented. Since both peripherally and centrally the hydroxytryptophan appears to act by being converted into serotonin, the present method allows one to increase the cerebral serotonin and to maintain some of its pharmacological effects on the brain and yet at the same time to avoid some of the actions of the excess serotonin in the other organs. It cannot be said whether or not all of the actions of serotonin on peripheral tissues have been circumvented by the BAS. This point must await further study. Nevertheless, one of its most objectionable effects, viz., the diarrhea, was completely eliminated by the antimetabolite.
The evidence that BAS does not enter the central nervous system freely is not entirely conclusive. The chief point in favor of such a view is that, in human beings, BAS does not cause psychiatric difficulties or hallucinations when it is given in doses large enough to prevent the pressor and intestinal actions of peripherally injected serotonin.13 Many other antimetabolites of serotonin do cause profound psychiatric difficulties.1' 2, 8 The success of BAS in avoidance of psychiatric effects is presumably due to exclusion of it from some parts of the brain. Nevertheless, this success could also be due to some failure of BAS to combine with the serotonin receptors of the brain, even though it does combine with those in several other tissues. However, the observation that direct injection of BAS into the brains of mice brought about a profound change in behavior would speak in favor of poor penetration from the periphery. Up to the present it has been impossible to decide this question by direct chemical measurement of how much does actually get into the brain, because of failure to recover BAS added to tissues. Until satisfactory recoveries can be achieved, one must be content with the indirect evidence. The results of the present study indicate either that the BAS did not penetrate readily into all parts of the brain or that it was poorly able to antagonize serotonin in some of its functions in the brain. By contrast, one piece of evidence exists to show that BAS does have some sort of action on the central nervous system. In humans and in mice large doses have a tranquillizing effect.
The marked changes in behavior of BAS-treated mice when the dose of 5-hydroxytryptophan was altered are noteworthy. With 2.5 mg. per mouse the picture was one of deep tranquillization or lethargy. With 15 mg. it was one of great excitement approaching convulsions. Our own earlier studies in mice and those of others with dogs, rabbits, and rats given serotonin by direct installation into the brain have shown that the most prominent effect is to induce lethargy. As the dose is increased to very large amounts (compared to that normally present in the brain), convulsions appear. It is possible (for theory see Shaw and Woolley7, 14) that these large doses are acting specifically to block and inactivate the serotonin recep- There is evidence from several sources that the quantum efficiency of photosynthesis begins to decline at wave-lengths where light absorption by chlorophyll is still strong.. Emerson and Lewis' found a sharp drop in efficiency beyond 685 my for both Chlorella and Chroococcus. Tanada2 found a similar decline for the diatom Navicula minima at about the same wave length. Action spectra measured by Haxo and Blinks3 for representatives of the green and brown algae also indicate declining photosynthetic efficiency beyond the red maximum of chlorophyll absorption.
It has seemed plausible to Rabinowitch,4 Duysens,5 and others that photosynthesis is brought about entirely by the lowest excited electronic state of chlorophyll a; yet this appears to conflict with the evidence of declining photosynthetic activity within the red absorption band of chlorophyll. Absorption anywhere within the red band, followed by vibrational equilibration with the medium, should bring the chlorophyll molecule into the same excited electronic state, with the same (temperature-determined) vibrational distribution (cf. Rabinowitch,
